908 Devices’ (MASS) “Sell (E+)” Rating Reiterated at Weiss Ratings

Weiss Ratings reissued their sell (e+) rating on shares of 908 Devices (NASDAQ:MASS) in a research report sent to investors on Saturday morning,Weiss Ratings reports.

A number of other research analysts have also weighed in on the stock. Leerink Partners reaffirmed a “market perform” rating and issued a $4.00 price target (down previously from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Leerink Partnrs cut shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 13th. Stephens reiterated an “overweight” rating and set a $6.00 target price on shares of 908 Devices in a report on Wednesday, January 15th. Finally, Stifel Nicolaus cut their price target on 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $5.33.

908 Devices Price Performance

NASDAQ:MASS opened at $2.98 on Friday. The business’s 50-day simple moving average is $2.35 and its 200-day simple moving average is $3.48. 908 Devices has a fifty-two week low of $1.81 and a fifty-two week high of $8.50. The stock has a market capitalization of $103.76 million, a PE ratio of -1.68 and a beta of 0.96.

Institutional Investors Weigh In On 908 Devices

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. SG Americas Securities LLC bought a new stake in 908 Devices during the third quarter worth about $36,000. B. Riley Wealth Advisors Inc. acquired a new position in shares of 908 Devices during the 3rd quarter worth approximately $45,000. Drive Wealth Management LLC bought a new stake in shares of 908 Devices during the 3rd quarter worth approximately $50,000. Townsquare Capital LLC acquired a new stake in shares of 908 Devices in the 3rd quarter valued at approximately $50,000. Finally, 49 Wealth Management LLC grew its stake in shares of 908 Devices by 16.2% in the third quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock valued at $108,000 after buying an additional 4,343 shares in the last quarter. 88.06% of the stock is owned by institutional investors.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.